SAFETY, EFFICACY AND CONVENIENCE OF TOBRAMYCIN INHALATION POWDER IN CYSTIC FIBROSIS PATIENTS: THE EAGER TRIAL

BACKGROUND: A light-porous-particle, dry-powder formulation of tobramycin was developed, using PulmoSphere® technology, to improve airway delivery efficiency, substantially reduce delivery time, and improve patient convenience and satisfaction. We evaluated the safety, efficacy and convenience of to...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Konstan, Michael W, Flume, Patrick A, Kappler, Matthias, Chiron, Raphaël, Higgins, Mark, Brockhaus, Florian, Zhang, Jie, Angyalosi, Gerhild, He, Ellie, Geller, David E
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086197/
https://ncbi.nlm.nih.gov/pubmed/21075062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2010.10.003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires